1. Bajaj N, Singh P. Therapeutic uses of Soft Contact Lenses. 2016;4(11). doi:10.18535/jmscr/v4i11.36.
2. Brinchmann-Hansen O, ANMARKRUD N, BRINCHMANNHANSEN O, ANMARKRUD N. Pilocarpine medication in open-angle glaucoma. A study using pilocarpine eyedrops and an ocular therapeutic system. ACTA Ophthalmol. 1979;57(1):55-62. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med1&NEWS=N&AN=419977.
3. Ciolino JB, Dohlman CH, Kohane DS. Contact lenses for drug delivery. Semin Ophthalmol. 2009;24(3):156-160. doi:10.1080/08820530902802161.
4. Peng CC, Burke MT, Carbia BE, Plummer C, Chauhan A. Extended drug delivery by contact lenses for glaucoma therapy. J Control Release. 2012;162(1):152-158. doi:10.1016/j.jconrel.2012.06.017.
5. Hillman JS, Marsters JB, Broad A. Pilocarpine delivery by hydrophilic lens in the management of acute glaucoma. Trans Ophthalmol Soc U K. 1975;95(1):79-84. http://www.ncbi.nlm.nih.gov/pubmed/1064215.
6. 6Xinming L, Yingde C, Lloyd AW, et al. Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: A review. Contact Lens Anterior Eye. 2008;31(2):57-64. doi:10.1016/j.clae.2007.09.002.
7. 7 Suvajac G. [Soft-contact-lenses-induced complications]. Vojnosanit Pregl. 2008;65 (1):15-20.
8. Guzman-Aranguez A, Colligris B, Pintor J. Contact lenses: promising devices for ocular drug delivery. J Ocul Pharmacol Ther. 2013;29(2):189-199. doi:10.1089/jop.2012.0212.